By every measure, that spending is on the rise; by drug “list price,” the increase is astronomical—from $636 billion in 2018 to $917 billion in 2023. What exactly are PBMs saving us from ...

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in mouse models. Could they help eliminate malaria in the future?

That report lists three proposed models: the Medicare High-Value Drug List Model, the Cell & Gene Therapy Access Model and the Accelerating Clinical Evidence Model. The first model allows Part D ...

Common medications might hold the key to preventing dementia, according to a vast study. Repurposing drugs like antibiotics could offer a swift and economical approach to managing dementia, suggesting ...

A major new analysis involving more than 130million people has revealed that five types of commonly taken medications could raise the risk of dementia. Antipsychotics, some medications for high ...

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

China’s healthcare regulator has pledged to investigate the quality of drugs under a new list covered by national insurance, after policy advisers in Shanghai warned that they might be substandard.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

Blockbuster obesity drugs such as Ozempic have been celebrated for their ability to promote weight loss and treat a surprising range of other conditions, from heart problems to Parkinson’s disease.

had until Feb. 1 to release the list, but officials said the agency had routinely been ahead of schedule throughout the process. Coupled with the first 10 drugs that have already been negotiated ...